// App-Quantinova.ai

314 : Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells

Researchers

Presenter

  • Kimberley A. Beaumont

Principal Investigators

  • David S. Hill

  • Sheena M. Daignault

  • Danae M. Sharp

  • Brian Gabrielli

  • Wolfgang Weninger

  • Nikolas K. Haass

Medical Centers

  • The Centenary Institute, Newtown, Australia

  • The University of Queensland Diamantina Institute, Woolloongabba, Australia.

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase

Drug/Treatment

  • Temozolomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved